You have 9 free searches left this month | for more free features.

Condition

Relapsing-remitting Multiple Sclerosis (2)

Multiple Sclerosis (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

EMD Serono Research & Development Institute, Inc. (1)

IMS HEALTH GmbH & Co. OHG (1)

Yale University (1)

Collaborator

EMD Serono (1)

Merck KGaA, Darmstadt, Germany (1)

Intervention

tecfidera (3)

evobrutinib (1)

placebo (1)

rebif (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Observational (2)

Interventional (1)

tecfidera

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Relapsing-remitting Multiple Sclerosis Trial in Worldwide (Evobrutinib, Placebo, Tecfidera)

Active, not recruiting

Has Results

Relapsing-remitting Multiple Sclerosis

Evobrutinib
+2 more

Blagoevgrad, Bulgaria
+55 more

May 4, 2021

Patient Real-world Clinical, Neurological, Tolerability, and

Completed

Relapsing-remitting Multiple Sclerosis

Rebif
Tecfidera

Birmingham, Alabama
+22 more

Feb 28, 2018

Restoring Glutathione Synthesis With Tecfidera: An in Vivo H-MRS

Terminated

Multiple Sclerosis

Tecfidera

New Haven, Connecticut

Yale University

Sep 2, 2016